EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Haematologica

ISSN 1592-8721 · Ferrata Storti Foundation (Haematologica)

Neueste Artikel

  1. Allogeneic hematopoietic stem cell transplantation after CD19-directed CAR T-cell therapy in children and adults with B-cell acute lymphoblastic leukemia: a GoCART coalition study on behalf of the PDWP, ALWP, and CTIWP of the EBMT

    Giorgio Ottaviano, Anna Alonso-Saladrigues, Valentin Ortiz-Maldonado, Jacques-Emmanuel Galimard, Shatha Farhan, Sowjana Vuyyala, Eva Michel, Fizza Imran, Nuria Martinez-Cibrián, Samppa Ryhänen, Andishe Attarbaschi, Stephan Mielke, Jürgen Kuball, Antonio Perez Martinez, Yves Beguin, Arnon Nagler, Anne-Charlotte Teyssier, Soeren Lykke Petersen, Pere Barba, Júlia Marsal, Julio Delgado, Krzysztof Kalwak, Fabio Ciceri, Annalisa Ruggeri, Sebastian Giebel, Susana Rives, Adriana Balduzzi

    Erschienen: 2026-11-19DOI: 10.3324/haematol.2026.301354

  2. Characterization and impact of response to holding/bridging therapy in second-line large Bcell lymphoma patients treated with axicabtagene ciloleucel: a LYSA study from the French DESCAR-T registry

    Antoine Capes, Caroline Rossoni, Elodie Gat, Guillaume Cartron, François-Xavier Gros, Emmanuel Bachy, Guillaume Manson, Gabriel Brisou, Catherine Thieblemont, Stéphanie Guidez, Laurianne Drieu La Rochelle, Rémy Dulery, Florent Malard, Fabrice Jardin, Benoît Tessoulin, Fabien Le Bras, Franck Morschhauser, Amandine Durand, Cristina Castilla Llorente, Pierre Bories, Michaël Loschi, Sylvain Choquet, Gandhi-Laurent Damaj, Marie-Thérèse Rubio, Aline Tanguy-Schmidt, Jacques-Olivier Bay, Magalie Joris, Sylvain Carras, Laure Lebras, Julie Abraham, Jean-Valère Malfuson, Ludovic Fouillet, Olivier Hermine, Adrien Chauchet, Laura Herbreteau, Blandine Guffroy, Justine Decroocq, Steven Le Gouill, Roch Houot, Estelle Bourbon

    Erschienen: 2026-11-19DOI: 10.3324/haematol.2026.301559

  3. Outcomes associated with CD3xCD20 bispecific antibody therapies in relapsed/refractory transformed indolent lymphoma

    Pierre Stephan, Karan L. Chohan, Robert A. Redd, Wendy Dixon, Aaron Zou, Sairah Ahmed, Christopher R. Flowers, Ayushi Chauhan, Amy A. Ayers, Geoffrey Shouse, Swetha Kambhampati Thiruvengadam, Alex F. Herrera, Allison M. Bock, Narendranath Epperla, Matthew A. Lunning, Gilles Salles, Lorenzo Falchi, Yazeed Sawalha, Sonia Godbole, Andrew P. Jallouk, Shakthi T. Bhaskar, Ajay Major, Steven M. Bair, Scott J. Rodig, Philippe Armand, Reid W. Merryman, Alexey V. Danilov, Jennifer L. Crombie

    Erschienen: 2026-11-19DOI: 10.3324/haematol.2026.301578

  4. Reduced intensity hematopoietic cell transplant using best available donor and posttransplant cyclophosphamide is safe and curative for transfusion-dependent thalassemia

    Yiouli P. Ktena, Megan Burris, Rebecca Berger, Kathryn Duke, Sara Newton, Kristen Rodenbush, Jessica D. Murphy, Lisa Vindiola, Liam M. Cooke, Hua-Ling Tsai, Challice L. Bonifant, Allen R. Chen, Christopher J. Gamper, Nicolas J. Llosa, Elias T. Zambidis, Katherine Liddle, Richard J. Jones, Javier Bolaños-Meade, Heather J. Symons, Kenneth R. Cooke

    Erschienen: 2026-11-19DOI: 10.3324/haematol.2026.301748

  5. Onset-subtype-dependent diagnostic performance of serum hyaluronic acid for sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation

    Shinsuke Takagi, Shogo Matsui, Tomoyo Kubo, Mika Kuno, Rikako Tabata, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Hisashi Yamamoto, Yuki Asano-Mori, Go Yamamoto, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida

    Erschienen: 2026-11-12DOI: 10.3324/haematol.2026.301096

  6. Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome

    Claudio Cerchione, Nour Alassi, Delia Cangini, Sarah Tassinari, Asia Spedaluzzi, Irene Azzali, Sofia Cortesi, Giacomo Feliciani, Alice Rossi, Sonia Ronconi, Michela Ceccolini, Michela Tonelli, Gerardo Musuraca, Nicola Normanno, Emanuela Scarpi, Giorgia Simonetti, Giovanni Martinelli, Paul G. Richardson, Matteo Marchesini

    Erschienen: 2026-11-12DOI: 10.3324/haematol.2026.301504

  7. Transcriptional landscape of nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma: tumor microenvironment and checkpoint genes

    Ilja Kalashnikov, Veronica Russell, Rachel Kositsky, Leonardo P.A. Biral, Panu Kovanen, Johannes Dunkel, Marja-Liisa Karjalainen-Lindsberg, Annika Pasanen, Devang Thakkar, Jean L. Koff, David Jaye, Sarah Ondrejka, Eric D. Hsi, Emily F. Mason, Ridas Juskevicius, Cassandra Love, Jennifer R. Shingleton, Elizabeth Thacker, Lanie Happ, Clay Parker, Tushar Dave, Mette Ølgod Pedersen, Magdalena Czader, Jiehao Zhou, Dennis O'Malley, Mina Xu, Andrew Evans, Chee Leong Cheng, Matthew McKinney, Chad M. McCall, Eric Tse, Rex Au Yeung, Yasodha Natkunam, Abner Louissaint Jr., Jennifer Chapman, Catalina Amador, Amy Chadburn, Yuri Fedoriw, Amir Behdad, Carlos Galvez

    Erschienen: 2026-11-12DOI: 10.3324/haematol.2026.301728

  8. Prospective study of longitudinal geriatric assessment with risk-adapted interventions for older patients in allogeneic hematopoietic cell transplantation

    Richard J. Lin, Soo Jung Kim, Samantha Brown, Danielle M. Lutrario, Danielle E. Engstler, Lauren Arnold, Ioannis Politikos, Boglarka Gyurkocza, Roni Tamari, Esperanza B. Papadopoulos, Ann A. Jakubowski, Parastoo B. Dahi, Amethyst Saldia, Yetunde Aremu, Raajit K. Rampal, Aaron D. Goldberg, Mark B. Geyer, Eytan M. Stein, Miguel-Angel Perales, Beatriz Korc-Grodzicki, Sean M. Devlin, Sarah Samorodnitsky, Armin Shahrokni, Sergio A. Giralt

    Erschienen: 2026-11-05DOI: 10.3324/haematol.2026.301206

Jahrgänge

2026 · 9072025 · 5442024 · 4762023 · 4482022 · 4062021 · 3302020 · 7802019 · 4972018 · 4152017 · 3762016 · 3232015 · 3592014 · 3512013 · 3692012 · 3452011 · 3372010 · 3772009 · 3302008 · 4272007 · 3961994 · 4

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.